NEWB

COM:NEWBURYPHARMA

Newbury Pharma

Stock

SEK

Last Close

3.32

25/11 08:40

Market Cap

91.21M

Beta: -

Volume Today

4.70K

Avg: -

Overview Analysis Metrics Financials Filings API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Aug '21	Aug '22	Aug '23	Aug '24
revenue	2.83M -	5.52M 94.98%	10.27M 86.11%	36.83M 258.75%
cost of revenue	2.37M -	3.95M 66.82%	6.32M 59.87%	20.80M 229.15%
gross profit	460K -	1.56M 240%	3.95M 152.43%	16.03M 306.10%
selling and marketing expenses
general and administrative expenses	2.81M -
selling general and administrative expenses	2.81M -
research and development expenses
other expenses				30.11M -
cost and expenses	8.45M -	17.89M 111.76%	27.48M 53.59%	50.91M 85.22%
operating expenses	6.08M -	13.94M 129.27%	21.17M 51.81%	30.11M 42.26%
interest expense	35K -
ebitda	-4.91M -	-13.66M 178.00%	-18.18M 33.05%	-12.34M 32.11%
operating income	-5.62M -	-14.67M 160.93%	-19.59M 33.54%	-14.08M 28.13%
depreciation and amortization	608K -	1.01M 65.46%	1.25M 24.75%	1.74M 38.49%
total other income expenses net	64K -		156K -	-1.33M 953.21%
income before tax	-5.56M -	-14.67M 163.94%	-19.43M 32.48%	-15.41M 20.70%
income tax expense	99K -		156K -	-4K 102.56%
net income	-5.56M -	-14.67M 163.94%	-19.43M 32.48%	-15.40M 20.72%
weighted average shs out	15.68M -	19.52M 24.54%	19.52M 0%	21.41M 9.68%
weighted average shs out dil	15.68M -	19.52M 24.54%	19.52M 0%	21.41M 9.68%
eps	-0.35 -	-0.75 114.29%	-1 33.33%	-0.72 28.00%
epsdiluted	-0.35 -	-0.75 114.29%	-1 33.33%	-0.72 28.00%

All numbers in SEK (except ratios and percentages)